Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2012 Apr;50(4):1452–1454. doi: 10.1128/JCM.06514-11

Variation of B1 Gene and AF146527 Repeat Element Copy Numbers According to Toxoplasma gondii Strains Assessed Using Real-Time Quantitative PCR

Jean-Marc Costa a,b, Stéphane Bretagne a,c,
PMCID: PMC3318569  PMID: 22259209

Abstract

Using the multicopy B1 gene and AF146527 element for the amplification of Toxoplasma gondii DNA raises the issue of reliable quantification for clinical diagnosis. We applied relative quantification to reference strains using the single-copy P30 gene as a reference. According to the parasite type, the copy numbers for the B1 gene and AF146527 element were found to be 5 to 12 and 4 to 8 times lower than the previous estimations of 35 and 230 copies, respectively.

TEXT

The diagnosis of diseases resulting from the protozoan parasite Toxoplasma gondii utilizes PCR for both immunocompromised patients (3, 17) and congenital diseases (9, 11, 12, 21). Over the past decade, PCR methods have evolved from endpoint PCR toward real-time quantitative PCR (qPCR), which is characterized by using a closed-tube method with a low risk of contamination with PCR products (2). This method provides quantitative results, which help clinicians in the management of congenital diseases (9) and Toxoplasma encephalitis (10, 17).

To improve sensitivity, the targeted sequence has developed from single-copy genes, such as P30 (5), to the repeated B1 gene (3, 11) and the 529-bp repeat element (AF146527) (13, 19). However, targeting multicopy genes has several issues. One challenge is deciphering the number of repeats for each strain, while another is choosing primers and probes based on conserved sequences from among the different repeats of the three major T. gondii lineages (20), with the aim of avoiding false negativity and quantification errors. We applied the E-method (22) to determine the relative quantification of the B1 gene and AF146527 (or AF487550) (19) repeat element on several T. gondii reference strains. The E-method compensated for differences in target and reference gene amplification efficiency, thus reducing calculation errors compared with the threshold cycle (ΔΔCT) method (16).

Overall, 12 reference strains pertaining to the three different T. gondii types were used (Table 1). Total DNA was extracted from 40 μl of a suspension of 108 tachyzoites per ml using the Roche Diagnostics total nucleic acid isolation kit (Roche Diagnostics, Meylan, France) on a MagNA Pure compact apparatus and eluted with 100 μl of elution buffer.

Table 1.

Mean ratios for relative quantification of the B1 gene and AF146527 repeat element compared to the single-copy P30 gene in different strains of Toxoplasma gondiia

Gene copy ratio Type I
Type II
Type III
P valueb
Strain name Mean (SD) ratio
Strain name Mean (SD) ratio
Strain name Mean (SD) ratio
Strain Type Strain Type Strain Type
B1/P30 RH 7.1 (0.7) 7.3 (2.0) B7 2.5 (0.0) 2.9 (0.3) STRL 4.0 (0.2) 4.9 (0.7) 0.01
VEL 6.4 (0.4) H44 2.7 (0.3) VEG 4.9 (0.3)
ENT 10.2 (0.8) Me49 3.1 (0.2) C5 5.8 (0.5)
GT-1 5.7 (0.2) PIH 3.2 (0.1) CTG 4.9 (0.2)
AF146527/P30 RH 30.4 (5.4) 24.3 (4.2) B7 52.3 (5.5) 53.7 (10.2) STRL 49.1 (2.6) 46.9 (6.2) 0.02
VEL 23.8 (0.5) H44 57.8 (3.2) VEG 53.7 (5.9)
ENT 21.8 (1.1) Me49 40.3 (2.6) C5 39.0 (2.4)
GT-1 21.1 (0.6) PIH 64.3 (1.6) CTG 46.0 (4.8)
AF146527/B1 RH 4.3 (0.7) 3.5 (0.9) B7 20.7 (1.9) 18.8 (3.9) STRL 12.4 (1.0) 9.9 (2.4) 0.01
VEL 3.7 (0.3) H44 21.3 (3.2) VEG 11.1 (1.9)
ENT 2.1 (0.2) Me49 13.0 (0.3) C5 6.8 (0.4)
GT-1 3.7 (0.1) PIH 20.0 (0.6) CTG 9.4 (1.4)
a

T. gondii was harvested on human foreskin fibroblast culture, as described at http://sibleylab.wustl.edu/pdf/Toxo_Harvesting.pdf. Mean values are based on three independent experiments, with ratios calculated automatically using relative quantification software with qPCR efficiency specific for each T. gondii type.

b

Kruskal-Wallis rank sum test, with P < 0.05 considered significant.

Partial sequences of the P30 gene, B1 gene, and AF146527 repeat element were obtained for all strains using the conventional cycle-sequencing Sanger method (7). Primers for relative quantification were then selected using Oligo 6.0 software among 100% conserved regions and designed to obtain similar sizes for the amplified products in order to achieve a better balance in the amplification yield (Table 2). BLAST analysis of the T. gondii genome confirmed that each primer set targeted a single, specific locus.

Table 2.

Primers and probes used in the present study

Primer or probe (GenBank accession no.) Sequence PCR product size (bp) Modification
P30 gene (AY187278) 126
    P30-1 5′-AGTTCCAATCGAGAAGTTCCC-3′ None
    P30-2 5′-TTATTGACGACCGATGAGGC-3′ None
    P30-3 5′-CAACCGACCACAAACGTCTGCG-3′ 5′LCRed640 3′Ph
    P30-4 5′-CAACTCTGTGCGTCGTCTCCCTTGAT-3′ 3′ FITC
B1 gene (AF179871) 132
    B1-1 5′-TCTCTCAAGGAGGACTGGCA-3′ None
    B1-2 5′-GTTTCACCCGGACCGTTTAG-3′ None
    B1-3 5′-ACGGGCGAGTAGCACCTGAGGAG-3′ 5′LCRed640 3′Ph
    B1-4 5′-CGGAAATAGAAAGCCATGAGGCACTCC-3′ 3′ FITCa
AF146527 element (AF487550) 133
    CG-1 5′-GTTGGGAAGCGACGAGAGTC-3′ None
    CG-2 5′-ATTCTCTCCGCCATCACCAC-3′ None
    CG-3 5′-TGCGATCTAGACGAGACGACGCTTTC-3′ 5′LCRed640 3′Ph
    CG-4 5′-GGAGGGTGGAAAAGAGACACCGGA-3′ 3′ FITC
a

FITC, fluorescein isothiocyanate.

To obtain the amplification efficiency for each DNA target and parasite type, PCRs were performed in triplicate as previously described (19), with serial 10-fold dilutions of T. gondii DNA ranging from 8 × 104 to 80 parasites per PCR, with one strain representing each type, namely, the RH, B7, and C5 strains for types I, II, and III, respectively. Calibration curves were calculated by plotting the quantification cycle values against the logarithm of input DNA.

DNA of each strain (2.5 μl containing 103 parasite equivalents per reaction) was amplified in duplicate in order to determine the copy number of the B1 gene and AF146527 repeat element for each T. gondii strain. To avoid interrun variability, reactions were performed in the same multiwell plate in a single run. Relative quantification was calculated automatically using LightCycler 480 software based on the E-method, with the single-copy P30 gene as a reference. Results were expressed as the ratio of target to reference sequence.

PCR efficiencies ranged from 1.878 to 1.989, depending on the combination of PCR targets and strain types. Thus, the relative quantifications of the B1 gene and AF146527 repeat element were calculated for each strain based on the PCR efficiency of the corresponding type. The difference was found to be significant for the B1/P30 and AF146527/P30 ratios (Table 1). When comparing the results according to type, using the Mann-Whitney-Wilcoxon test, type 2 B1/P30 ratios were found to be different from the other B1/P30 ratios (P < 0.03), while the AF146527/P30 ratios all differed from each other (P < 0.03). Whether this finding can enhance known genotyping methods or not still needs to be confirmed using an extended sampling.

The copy numbers for the B1 gene were observed to be 5, 12, and 7 times lower than the previous estimation of 35 (4) for the three different T. gondii types, respectively, and at least 8, 4, and 4 times lower than the 200 to 300 copies reported for the AF146527 element (13). These discrepancies may be explained by the possible overestimation of the copy numbers in previous studies. Quantification was historically performed with blotting following conventional PCR, and the signals were compared between quantified T. gondii DNA and a plasmid containing one copy of the gene (4, 13). Additionally, only type I T. gondii was tested (4, 13). These methods were subjective, with the quantification perhaps being only indicative. The discrepancies in copy numbers may also be accounted for by an underestimation based on the present relative quantification in relation to single nucleotide polymorphisms in the primer sequences between the different repeats. Indeed, Sanger's sequencing cannot detect sequence variations below a 20% threshold (14). However, this explanation appears unlikely.

While B1 and AF146527 copy numbers were below the levels previously published, we confirmed the higher copy number of AF146527 over B1, although the ratio varied according to the different types (Table 1). This finding is in agreement with the higher sensitivity observed in clinical specimens, where between 9.1% and 18.5% of AF146527-positive samples were reported to be B1 negative, supporting the use of the AF repeat element as the best target for a routine diagnostic (6, 15, 18). However, a recent publication performed on African patients suggested that the AF146527 locus cannot be amplified in certain samples (23). We reported a C/G mismatch at position 275 in one primer sequence under GenBank accession no. AF487550 (19), which may explain some of the amplification failures. Additionally, the strain types in Africa may differ from the common type II found in Europe (1, 8). Indeed, type II strains exhibit a higher AF146527/B1 ratio, which may explain the improved performance of PCR assays based on AF146527 in Europe compared with other geographical regions.

Our study highlighted the relevance of relative quantification for correctly identifying reference strains when comparing the analytical sensitivity of PCR assays based on multicopy genes. As human infections are mainly due to non-type I strains, using the type I RH strain may be misleading in terms of quantitative results.

ACKNOWLEDGMENTS

We deeply thank David Sibley and Asis Khan for providing the parasite lysates used in this study.

All authors report they have no potential conflicts of interest.

Footnotes

Published ahead of print 18 January 2012

REFERENCES

  • 1. Ajzenberg D, et al. 2009. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J. Infect. Dis. 199:1155–1167 [DOI] [PubMed] [Google Scholar]
  • 2. Bretagne S, Costa JM. 2006. Towards a nucleic acid-based diagnosis in clinical parasitology and mycology. Clin. Chim. Acta 363:221–228 [DOI] [PubMed] [Google Scholar]
  • 3. Bretagne S, et al. 1993. Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples. J. Infect. Dis. 168:1585–1588 [DOI] [PubMed] [Google Scholar]
  • 4. Burg JL, Grover CM, Pouletty P, Boothroyd JC. 1989. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 27:1787–1792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Burg JL, Perelman D, Kasper LH, Ware PL, Boothroyd JC. 1988. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 141:3584–3591 [PubMed] [Google Scholar]
  • 6. Cassaing S, et al. 2006. Comparison between two amplification sets for molecular diagnosis of toxoplasmosis by real-time PCR. J. Clin. Microbiol. 44:720–724 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Costa JM, Cabaret O, Moukoury S, Bretagne S. 2011. Genotyping of the protozoan pathogen Toxoplasma gondii using high-resolution melting analysis of the repeated B1 gene. J. Microbiol. Methods 86:357–363 [DOI] [PubMed] [Google Scholar]
  • 8. Costa JM, Darde ML, Assouline B, Vidaud M, Bretagne S. 1997. Microsatellite in the beta-tubulin gene of Toxoplasma gondii as a new genetic marker for use in direct screening of amniotic fluids. J. Clin. Microbiol. 35:2542–2545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Costa JM, Ernault P, Gautier E, Bretagne S. 2001. Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes. Prenat. Diagn. 21:85–88 [DOI] [PubMed] [Google Scholar]
  • 10. Costa JM, et al. 2000. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J. Clin. Microbiol. 38:2929–2932 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Grover CM, Thulliez P, Remington JS, Boothroyd JC. 1990. Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction and amniotic fluid. J. Clin. Microbiol. 28:2297–2301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Hohlfeld P, et al. 1994. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N. Engl. J. Med. 331:695–699 [DOI] [PubMed] [Google Scholar]
  • 13. Homan WL, Vercammen M, De Braekeleer J, Verschueren H. 2000. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int. J. Parasitol. 30:69–75 [DOI] [PubMed] [Google Scholar]
  • 14. Hurst CD, Zuiverloon TC, Hafner C, Zwarthoff EC, Knowles MA. 2009. A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene. BMC Res. Notes 2:66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Kasper DC, et al. 2009. Quantitative real-time polymerase chain reaction for the accurate detection of Toxoplasma gondii in amniotic fluid. Diagn. Microbiol. Infect. Dis. 63:10–15 [DOI] [PubMed] [Google Scholar]
  • 16. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−CT method. Methods 25:402–408 [DOI] [PubMed] [Google Scholar]
  • 17. Martino R, et al. 2005. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin. Infect. Dis. 40:67–78 [DOI] [PubMed] [Google Scholar]
  • 18. Menotti J, et al. 2010. Evaluation of a new 5′-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat. Clin. Microbiol. Infect. 16:363–368 [DOI] [PubMed] [Google Scholar]
  • 19. Reischl U, Bretagne S, Kruger D, Ernault P, Costa JM. 2003. Comparison of two DNA targets for the diagnosis of toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect. Dis. 3:7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Saeij JP, Boyle JP, Boothroyd JC. 2005. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 21:476–481 [DOI] [PubMed] [Google Scholar]
  • 21. Savva D, Morris JC, Johnson JD, Holliman RE. 1990. Polymerase chain reaction for detection of Toxoplasma gondii. J. Med. Microbiol. 32:25–31 [DOI] [PubMed] [Google Scholar]
  • 22. Tellmann G. 2006. The E-method: a highly accurate technique for gene-expression analysis. Nat. Methods 3:i–ii [Google Scholar]
  • 23. Wahab T, Edvinsson B, Palm D, Lindh J. 2010. Comparison of the AF146527 and B1 repeated elements, two real-time PCR targets used for detection of Toxoplasma gondii. J. Clin. Microbiol. 48:591–592 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES